Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a “one size fits all” approach?

MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis

(2014) J. Huan et al.   JOURNAL OF IMMUNOLOGY

Reversal of type 1 diabetes by a new MHC II-peptide chimera: “Single-epitope-mediated suppression” to stabilize a polyclonal autoimmune T-cell process

(2010) Marvin Lin et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Long and Winding Road to Understanding and Conquering Type 1 Diabetes

(2010) Pere Santamaria   IMMUNITY

Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells

(2010) Sue Tsai et al.   IMMUNITY

A Promising Therapeutic Approach for Treatment of Posterior Uveitis: Recombinant T Cell Receptor Ligand Protects Lewis Rats from Acute and Recurrent Experimental Autoimmune Uveitis

(2010) Grazyna Adamus et al.   OPHTHALMIC RESEARCH

In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation

(2010) J. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Thymus-specific deletion of insulin induces autoimmune diabetes

(2009) Yong Fan et al.   EMBO JOURNAL

Suppression of Ongoing T Cell-Mediated Autoimmunity by Peptide-MHC Class II Dimer Vaccination

(2009) L. Li et al.   JOURNAL OF IMMUNOLOGY

Recombinant TCR Ligand Reverses Clinical Signs and CNS Damage of EAE Induced by Recombinant Human MOG

(2009) Sushmita Sinha et al.   Journal of Neuroimmune Pharmacology

Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand

(2009) S. Sinha et al.   JOURNAL OF NEUROSCIENCE

Recombinant T Cell Receptor Ligand Treats Experimental Stroke

(2009) Sandhya Subramanian et al.   STROKE

A Peptide-Major Histocompatibility Complex II Chimera Favors Survival of Pancreatic β-Ιslets Grafted in Type 1 Diabetic Mice

(2009) Sofia Casares et al.   TRANSPLANTATION